HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laszlo Mark Selected Research

HO-3538

9/2006A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laszlo Mark Research Topics

Disease

3Squamous Cell Carcinoma of Head and Neck
10/2020 - 07/2012
3Hemorrhage
02/2015 - 02/2005
2Neoplasms (Cancer)
10/2020 - 07/2014
1Acute Coronary Syndrome
01/2020
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2016
1Cardiovascular Diseases (Cardiovascular Disease)
07/2015
1Atrial Fibrillation
02/2015
1Osteosarcoma (Osteogenic Sarcoma)
01/2014
1Hyperlipidemias (Hyperlipidemia)
06/2013
1Dyslipidemias (Dyslipidemia)
09/2012
1Cleft Lip (Harelip)
09/2012
1Ganglion Cysts (Ganglion)
11/2010
1Hypertrophy
06/2009
1Fibrosis (Cirrhosis)
06/2009
1Cardiomegaly (Heart Hypertrophy)
06/2009
1Septic Shock (Toxic Shock Syndrome)
02/2009
1Hypercholesterolemia
07/2007
1Coronary Disease (Coronary Heart Disease)
07/2007
1Reperfusion Injury
09/2006
1Wounds and Injuries (Trauma)
09/2006
1Infarction (Infarctions)
09/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2020 - 09/2006
3Biomarkers (Surrogate Marker)IBA
07/2014 - 07/2012
2Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2016 - 11/2010
2AnticoagulantsIBA
02/2015 - 04/2006
2LipidsIBA
06/2013 - 07/2007
2LDL CholesterolIBA
09/2012 - 07/2007
2oxidized low density lipoproteinIBA
09/2012 - 07/2007
2PolyphenolsIBA
06/2009 - 02/2009
2AcenocoumarolIBA
04/2006 - 02/2005
2Cytochrome P-450 CYP2C9IBA
04/2006 - 02/2005
1Cytoplasmic DyneinsIBA
10/2020
1Type I Keratins (Type I Keratin)IBA
10/2020
1Formaldehyde (Formol)FDA Link
10/2020
1TenascinIBA
10/2020
1Small Nuclear Ribonucleoproteins (snRNP)IBA
10/2020
1NucleolinIBA
10/2020
1ParaffinIBA
10/2020
1long-chain-aldehyde dehydrogenaseIBA
10/2020
1Cornified Envelope Proline-Rich ProteinsIBA
10/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020
1Triglycerides (Triacylglycerol)IBA
07/2015
1HDL CholesterolIBA
07/2015
1Vitamin KFDA Link
02/2015
1Tumor Biomarkers (Tumor Markers)IBA
01/2014
1Adaptor Protein Complex 3IBA
09/2012
1ProteomeIBA
09/2012
1nidogen (entactin)IBA
09/2012
1Salivary Proteins and PeptidesIBA
09/2012
1Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
11/2010
1insect maxadilan proteinIBA
11/2010
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2009
1Protein Kinase CIBA
06/2009
1Anthocyanins (Anthocyanin)IBA
06/2009
1LipopolysaccharidesIBA
02/2009
1ferulaldehydeIBA
02/2009
1Ezetimibe (Zetia)FDA Link
07/2007
1Lipoproteins (Lipoprotein)IBA
07/2007
1Apolipoproteins E (ApoE)IBA
07/2007
1ApolipoproteinsIBA
07/2007
1CholesterolIBA
07/2007
1Pharmaceutical PreparationsIBA
09/2006
1CalciumIBA
09/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2006
1HO-3538IBA
09/2006
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2005
1Fenofibrate (CiL)FDA LinkGeneric
01/2002

Therapy/Procedure

2Therapeutics
02/2015 - 04/2006
1Lasers (Laser)
09/2012